Stereochemically defined 1- and 1,2-substituted cyclopropylamines via novel synthetic methodology

Technology
Conceptual
University

A chemistry-driven synthetic approach to produce stereochemically defined 1- and 1,2-substituted cyclopropylamines, enabling isolation of both diastereomers. These rigid, metabolically stable building blocks serve as constrained phenethylamine equivalents relevant to pharmaceutical and agrochemical development.

Overview

Cyclopropylamines (aminocyclopropanes) are valuable structural motifs found in numerous pharmaceuticals and agrochemicals. The 2-aryl cyclopropylamine framework is particularly attractive because it acts as a rigid and metabolically stable bioisostere for phenethylamine derivatives, offering improved pharmacokinetic properties and conformational control in drug design.

This research delivers a new synthetic methodology that enables the preparation of stereochemically defined 1- and 1,2-substituted cyclopropylamines. A key advantage is that both diastereomers can be isolated, giving researchers full stereochemical control over these constrained amine building blocks for use in medicinal chemistry and crop science applications.

Technical specifications

Key features:

  • New synthetic methodology developed specifically for stereochemically defined cyclopropylamines
  • Access to 1-substituted and 1,2-substituted cyclopropylamine scaffolds
  • Isolation of both diastereomers, enabling complete stereochemical control
  • 2-aryl cyclopropylamine motif serves as a rigid, metabolically stable phenethylamine equivalent
  • Applicable to pharmaceutical and agrochemical discovery programs
Technology readiness level

The methodology has been developed and demonstrated in an academic research laboratory setting at the University of Toronto. The ability to isolate both diastereomers has been established. Further validation, scale-up studies, and application-specific testing would be required to advance toward broader adoption in industrial drug and agrochemical discovery workflows.


About University of Toronto

The University of Toronto is a comprehensive public research university with three campuses in the Toronto region and a globally scaled research enterprise. Its downtown footprint is embedded within a major academic health network and an adjacent innovation district, enabling co-located labs, clinical trials, and rapid testing with end users. Companies connect through co-op and long-duration internships, sponsored research, and access to shared core facilities and prototyping resources. Research is supported by Canada’s Tri‑Agency (NSERC, CIHR, SSHRC) and the Canada Foundation for Innovation, alongside provincial programs and industry partnerships. A dedicated technology transfer office provides IP management, licensing, and startup support through a coordinated entrepreneurship network.

Halo home
Partner smarter. Move faster.
Get new partnering requests
delivered to your inbox.